Atlas Arteria Ltd (ASX:ALX)
A$ 4.74 -0.04 (-0.84%) Market Cap: 6.88 Bil Enterprise Value: 8.31 Bil PE Ratio: 23.01 PB Ratio: 1.12 GF Score: 70/100

Half Year 2024 Atlas Arteria Group Earnings Call Transcript

Aug 29, 2024 / 12:30AM GMT
Release Date Price: A$5.06 (-0.59%)

Key Points

Positve
  • Strong growth in proportional toll revenue driven by inflation-linked toll increases.
  • Reaffirmed distribution guidance of $0.4 per security for 2024, supported by improved free cash flow.
  • On track to achieve 2025 emissions reduction targets, reflecting strong sustainability efforts.
  • Appointment of Hugh Wehby as new CEO, bringing extensive infrastructure experience.
  • Successful refinancing initiatives, enhancing balance sheet flexibility and reducing refinancing risks.
Negative
  • Negative impact on EBITDA due to the new French long-distance transportation infrastructure tax.
  • Traffic reduction at APRR due to pharma strikes and lower heavy vehicle traffic.
  • Increased operational costs at Dulles Greenway due to legal fees and new violation enforcement system.
  • Ongoing litigation and uncertainty surrounding the new French tax, which could take up to four years to resolve.
  • Higher labor costs at APRR due to wage escalation and prior period adjustments.
Operator

Thank you for standing by, and welcome to the Atlas Arteria H1 2024 results presentation. (Operator Instructions) Due to legal restrictions, we are only able to communicate directly with eligible shareholders and investors with respect to the eligibility to invest in Atlas Arteria securities. Details in relation to the ownership restrictions that apply to persons in the United States and other US persons that are not qualified purchasers are set out on our website under US ownership restrictions.

Please refrain from asking questions in relation to our securities, if you do not meet these criteria as we are legally restricted from answering those questions on this call. I would now like to hand the conference over to Mr. Graeme Bevans, Chief Executive Officer. Please go ahead.

Graeme Bevans
Atlas Arteria Group - Chief Executive Officer, Managing Director, Executive Director

Thank you, and good morning, everyone. We are pleased to have you join us for Atlas Arteria's first half 2024 results call. Today, I'm joined by our CFO, David Collins, and our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot